(Q44584672)

4 December 2017

title

Older women with breast carcinoma are less likely to receive adjuvant chemotherapy: evidence of possible age bias? (English)

1 reference

4 December 2017

1 reference

1 reference

1 reference

Stacy Woodard

1

1 reference

4 December 2017

Padma C Nadella

2

1 reference

4 December 2017

Linda Kotur

3

1 reference

4 December 2017

John Wilson

4

1 reference

4 December 2017

William E Burak

5

1 reference

4 December 2017

Charles L Shapiro

6

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

4 December 2017

1 reference

4 December 2017

volume

98

1 reference

4 December 2017

issue

6

1 reference

4 December 2017

page(s)

1141-1149

1 reference

Variation in staging and treatment of local and regional breast cancer in the elderly

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11640

7 January 2021

The effect of aging on the utilization of chemotherapy for metastatic breast cancer: a population-based study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11640

7 January 2021

The effect of age and comorbidity in the treatment of elderly women with nonmetastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11640

7 January 2021

Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11640

7 January 2021

Adjuvant systemic therapy for breast cancer in the elderly: competing causes of mortality. International Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11640

7 January 2021

Competing causes of death for primary breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11640

7 January 2021

Measuring comorbidity in older cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11640

7 January 2021

Epidemiology of breast cancer in older women: implications for future healthcare

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11640

7 January 2021

Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11640

7 January 2021

Comorbidity and functional status are independent in older cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11640

7 January 2021

Performance status and comorbidity in elderly cancer patients compared with young patients with neoplasia and elderly patients without neoplastic conditions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11640

7 January 2021

Management of breast cancer in the older woman

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11640

7 January 2021

Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11640

7 January 2021

Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11640

7 January 2021

A prospective pharmacologic evaluation of age-related toxicity of adjuvant chemotherapy in women with breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11640

7 January 2021

Doxorubicin-based adjuvant chemotherapy in elderly breast cancer patients: the M.D. Anderson experience, with long-term follow-up

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11640

7 January 2021

Cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy in women more than 65 years old with advanced breast cancer: the elimination of age trends in toxicity by using doses based on creatinine clearance

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11640

7 January 2021

Physician characteristics: do they influence the evaluation and treatment of breast cancer in older women?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11640

7 January 2021

Should the elderly receive chemotherapy for node-negative breast cancer? A cost-effectiveness analysis examining total and active life-expectancy outcomes.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11640

7 January 2021

What threshold for adjuvant therapy in older breast cancer patients?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11640

7 January 2021

Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11640

7 January 2021

Patient preferences for adjuvant chemotherapy of early breast cancer: how much benefit is needed?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11640

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11640

7 January 2021

Causes for the undertreatment of elderly breast cancer patients: tailoring treatments to individual patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11640

7 January 2021

Identifiers

DOI

10.1002/CNCR.11640

1 reference

4 December 2017

1 reference